Review Question - QID 109975

A 52-year-old woman status-post liver transplant presents to her transplant surgeon because she has noticed increased urination over the last 3 weeks. Six months ago she received a liver transplant because of fulminant liver failure after viral hepatitis. Since then, she has noticed that she has been drinking more water and urinating more. Her husband has also noticed that she has been eating a lot more. She says that she never had these symptoms prior to her transplant and has been taking her medications on time. After confirmatory tests, she is started on a medication that binds to an ATP-gated potassium channel. The drug that increases the risk of the complication experienced by this patient most likely has which of the following mechanisms of action?